Astonea Labs Limited

As of March 31, 2026, Astonea Labs Limited carries a market capitalization of 1.61B, placing it among publicly traded companies globally. Its enterprise value stands at 2.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Astonea Labs Limited has 10.51M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Astonea Labs Limited maintains a current ratio of 1.44, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Astonea Labs Limited recorded 7.50M in income tax expense.

As of the close on October 19, 2026, Astonea Labs Limited's stock has gained approximately 101.87% over the past 52 weeks. The 50-day moving average sits at 292.79, while the 200-day moving average is 202.63.

As of March 31, 2026, Astonea Labs Limited holds 1.79M in cash and equivalents against 430.04M in total debt, resulting in a net debt position of 428.25M. Total book value stands at 571.32M, with working capital of 302.01M providing operational flexibility.